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Abstract Previous tudies had shown that binding of TGF-fl to the small proteoglycan decorin results in its inactivation. Indeed, in osteosarcoma 
ceils the addition of decorin prevented the TGF-fll-mediated up-regulation f biglycan synthesis. However, the down-regulation fproteoglycan-100 
remained unaltered. Even in the presence of a 100,000-fold molar excess of decorin, TGF-fll was fully active in U937 monocytes with respect to the 
inhibition of cell proliferation. There was no inhibition of the TGF-fl-mediated stimulation of the retraction of fibroblast-populated collagen lattices. 
Thus, the formation of TGF-fl/decorin complexes leads to the neutralization fdistinct effects only. 
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1. Introduction 
The family of TGF-fl polypeptides represents multifunc- 
tional cytokines which are involved in the modulation of the 
differentiated phenotype, in the regulation of cell proliferation 
and in the synthesis and deposition of extracellular matrix pro- 
teins (see [1-3] for reviews). Although different TGF-fl isoforms 
are interchangeable in most in vitro assays, TGF-fl l  was con- 
sidered as playing a major role in stimulating the production 
of the extracellular matrix and regulating cell matrix interac- 
tions [4]. 
Strong evidence has been provided that TGF-fl is an essential 
factor during tissue repair after injury [1-3]. For example, 
TGF-fl has been shown to stimulate collagen-matrix contrac- 
tion by fibroblasts [5] and to induce the expression of fibrillar 
collagens [6]. Somewhat contradictory results have been ob- 
tained with respect to the effects of TGF-fl on small interstitial 
proteoglycan expression. An up-regulation ofbiglycan has con- 
sistently been noted. An increased production of the collagen- 
binding proteoglycan decorin has been observed in mesangial 
cells [7] but not in fibroblasts [8,9-11]. Another small proteogly- 
can, proteoglycan-100 (PG-100), was markedly down-regulated 
[9]. 
The beneficial effect of TGF-fl on tissue repair can be coun- 
teracted by excessive matrix deposition [12]. In a rat model, the 
development ofan acute proliferative glomerulonephritis could 
indeed be prevented by a neutralizing antiserum against TGF-fl 
[13]. It has also been shown that small proteoglycans them- 
selves form inactive complexes with the cytokine [14], and could 
therefore be of therapeutic value [15]. In this report data are 
presented which indicate that the interaction of decorin with 
TGF-fl interferes with distinct functions of the growth factor. 
2. Materials and methods 
after the incubations by SDS-PAGE and Western blotting [17]. SDS- 
PAGE indicated that the preparations were at least 95% pure. Antisera 
against biglycan, decorin and PG-100 were those used previously [17]. 
2.2. Cell culture and metabolic labeling 
Human osteosarcoma cells (MG-63), skin fibroblasts [9] and mon- 
ocyte-like U937 cells [18] were cultured as described. Fibroblast-popu- 
lated collagen lattices were prepared [19] with bovine serum albumin 
(BSA) in place of serum [9]. Before metabolic labeling, MG-63 cells 
were preincubated for 20 h with the indicated quantities of TGF-fl 
and/or decorin in serum-free MEM medium containing 1% BSA. Sub- 
sequent labeling with [35S]sulfate (4 h, 1.85 MBq/ml) was performed in
the presence of identical concentrations of reagents. U937 cells (106 cells 
in 5 ml RPMI 1640 medium) received 10/zM calcitriol together with 
the indicated quantities of TGF-fl and/or decorin for a period of 3 days. 
2.3. Proteoglycan quantification 
In most experiments cell-associated and secreted proteoglycans were 
sequentially immune precipitated with antisera gainst PG-100, de- 
corin, and biglycan [17]. The precipitations of PG-100 and biglycan 
were at least 90% complete. Decorin was not investigated further be- 
cause of incomplete precipitation i  the presence of excess of the unla- 
beled proteoglycan. 
2.4. Interaction of TGF-fl with collagen-bound decorin 
Purified acid-soluble type I collagen from calf skin, kindly provided 
by Dr. J. Rauterberg of this university, was dissolved in 10 mM acetic 
acid (2 mg/ml), sterilized and adjusted to 18 mM sodium phosphate, pH 
7.4, 0.137 M NaC1, 3 mM KCI (PBS) and 1% BSA. One ml of the 
solution, containing 1.1 mg collagen, was incubated for 5 h at 37°C in 
the absence or presence of 0.1/zM decorin. Fibrils were collected by 
centrifugation, washed twice with PBS/I% BSA and suspended in 1 ml 
RPMI 1640 medium/10/zM calcitriol with or without 50 pM TGF-fl. 
After 90 min at 37"C free TGF-fl and TGF-fl bound to the fibrils were 
separately quantitated by determining the growth-inhibitory effect on 
U937 cells. Prior to the assay, bound TGF-/~ was solubilized by digest- 
ing the washed collagen fibrils for 16 h at 37"C with 25 BTC-U of 
collagenase in 500/zl RPMI 1640 medium/10/zM calcitriol. In parallel 
experiments he quantity of collagen-bound decorin was obtained by 
including trace amounts of [35S]sulfate-labeled d corin in the assay 
mixture. 
2.1. Materials 
Human recombinant TGF-fll was from Serva, and collagenase from 
Advance Biofactures (Lynbrook, NY). Calcitriol was kindly provided 
by Dr. M.R. Uskokovic, Hoffmann-La Roche. Decorin was purified 
under non-denaturing conditions from the secretions of cultured 
human skin fibroblasts as described [16] and characterized before and 
*Corresponding author. 
3. Results 
In MG-63 osteosarcoma cells TGF-fl causes an up-regula- 
tion of biglycan, a marked down-regulation of PG-100 and a 
minor reduction ofdecorin synthesis [9]. Inactivation of TGF-fl 
by decorin would therefore be expected to interfere with oppo- 
site effects on proteoglycan biosynthesis. In three independent 
experiments, however, we found that only the TGF-fl-mediated 
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Table 1 
Influence of TGF-fl and TGF-fl/decorin complexes on biglycan and 
PG-100 biosynthesis in MG-63 cells 
Addition 
TGF-fl Decorin 
(pM) (nM) 
TGF-fl B ig lycan PG-100 
free* 
(pM) (10 -3 x cprrdflask) 
None none - 49 (100) 144 (100) 
None 100 - 54 (110) 188 (132) 
200 none 200 88 (180) 44 (31) 
20 none 20 80 (163) 114 (79) 
2 none 2 64 (131) 153 (106) 
200 100 3 50 (102) 46 (32) 
*Calculated under the assumption of Kd = 1.5 x 10 -9 M for the de- 
codn-TGF-fl interaction [14]. The concentration fdeeorin was calcu- 
lated from the hexuronic acid content assuming 65 residues per mole- 
cule [17]. Values in brackets how percent of untreated control. 
induction of biglycan biosynthesis (136-186% of control in the 
presence of 200 pM TGF-fl) was sensitive to decorin addition 
(102-108% of control with 200 pM TGF-fl/100 nM decorin). 
The inhibition of PG- 100 biosynthesis (26-31% of control at the 
same TGF-fl concentration) remained unaltered. One of the 
experiments is shown in Table 1. None of the treatments influ- 
enced the ratio between cell-associated and secreted proteogly- 
cans after a labeling period of 4 h (data not shown). 
It had been described previously [5] that TGF-fl stimulates 
the contraction of fibroblast-populated collagen lattices. It was, 
therefore, of interest o study the influence of TGF-fl/decorin 
complexes in this model where an insoluble matrix is present, 
comparable to the in vivo situation. Applying a 500-fold molar 
excess of decorin which is expected to decrease the quantity of 
free TGF-fl by 98.5%, at the most a marginal neutralizing effect 
on the activity of the cytokine was found in two separate xper- 
iments (Table 2). 
During the course of this study we found that picomolar 
doses of TGF-fl exhibited a marked anti-proliferative effect on 
monocytic U937 cells, which was accompanied by an alkalisa- 
tion of the culture medium. Using this extremely sensitive 
assay, in three independent experiments even a 100,000-fold 
excess of decorin was without influence on TGF-fl activity 
(Table 3). Because of the possibility of proteolytic degradation 
of decorin during the 3 day incubation period, decorin was 
analyzed by SDS-PAGE and Western blotting. Neither in the 
presence of 10 pM TGF-fl nor in its absence measurable degra- 
dation occurred. 
In addition to the question of the biological activity of solu- 
ble TGF-fl/decorin complexes, the problem has been consid- 
Table 2 
Influence of TGF-fl and TGF-fl/decorin complexes on collagen gel 
retraction 
Addition Time (h) 
TGF-fl Decorin 13 21 30 72 
(pM) (nM) Gel area (% of zero time) 
None none 25.0 20.7 11.1 4.2 
200 none 12.0 8.3 3.3 0.5 
20 none 19.0 14.4 9.2 3.9 
2 none 22.0 18.0 11.6 4.2 
200 100 13.0 8.8 3.9 0.7 
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ered whether collagen-bound decorin, i.e. the predominant in
vivo form of the proteoglycan, retains its ability to interact with 
TGF-fl. The U937 assay system was used to quantify TGF-fl 
(50 fmol per assay) upon interaction with either free type I 
collagen (1.1 mg) or decorin-containing collagen (30 pmoi/1.1 
mg). In the case of decorin-free collagen 0.6 fmol of the cytok- 
ine were found in association with collagen, and 36.5 fmol in 
the supernatant. Decorin-containing collagen bound 2.0 fmol 
and 47.5 fmol were found in the supernatant. Thus, collagen- 
bound decorin is still able to interact with TGF-fl albeit either 
with low affinity or with an unfavourable stoichiometry. 
4. Discussion 
The main observation described in this paper concerns the 
neutralization of only a selected TGF-fll-mediated effect by 
decorin. In two experimental models a negative influence of 
decorin on TGF-fl activity had been described. Under tissue 
culture conditions, i.e. under similar conditions as in this study, 
the expression of high levels of human decorin in CHO cells had 
a dramatic effect on cell growth ascribed to TGF-fl binding and 
inactivation [14]. This observation, however, defies a simple 
interpretation since wild-type CHO cells themselves produce 
large quantities of decorin (unpublished observation). In a rat 
model, injection of massive doses of decorin (450/tg/dose) 
prevented excessive matrix accumulation i  experimental giom- 
erulonephritis [15]. In this system complex formation between 
TGF-fl and decorin most likely occurs on solid phases thus 
withdrawing TGF-fl from the signalling receptors. In the simple 
solid phase model used in this study, contraction of fibroblast- 
populated collagen lattices, no alteration of the TGF-fl effect 
by decorin could be observed. 
The failure to observe the neutralisation of all TGF-fl-medi- 
ated effects by decorin cannot be explained by the endocytosis 
of the proteoglycan since its concentration is reduced by 3% 
only during the 4 h labeling period [17]. It is known that TGF-fl 
binds to cell membrane receptors with high affinity [2]. De- 
corin-bound TGF-fl should therefore be in an equilibrium with 
the receptor-bound cytokine. Although the respective quantita- 
tive data are not available, the consistent finding of an inactiva- 
tion of TGF-fl with respect o biglycan induction argues for a 
biologically relevant complex formation between decorin and 
TGF-fl. The selective inactivity of TGF-fl/decorin complexes, 
Table 3 
Influence of TGF-fl and TGF-fl/deeorin complexes on the proliferation 
of U937 cells 
Addition TGF-fl Cell number pH 
free* (10 -6 x m1-1) 
TGF-fl Decorin (pM) 
(pM) (nM) 
None none - 1.16 (100) 7.08 
None 100 - 1.20 (103) 7.02 
10 none 10 0.48 (41) 7.65 
1 none 1 0.75 (65) 7.36 
0.1 none 0.1 1.15 (99) 7.09 
0.01 none 0.01 1.15 (99) 7.07 
10 100 0.15 0.49 (42) 7.67 
1 100 0.015 0.80 (69) 7.30 
*Calculated under the assumption of K~ = 1.5 x 10 -9 M. Values in 
brackets how percent of untreated control. Measurements were per- 
formed after 3 days of incubation. 
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however, cannot be explained unambiguously. There exist at 
least two signalling TGF-fl receptors, both of which exhibit 
serine/threonine kinase activity and cooperate during binding 
and signal transfer [20,21]. Skin fibroblasts and MG-63 cells 
possess both receptors, whereas cross-linking experiments 
failed to detect he type II receptor in U937 cells [23]. According 
to the proposed necessity of receptor cooperation, the selective 
inactivity of TGF-fl/decorin complexes should not be caused by 
selective binding to one of the receptors but by the modulation 
of other steps of the signalling cascade. 
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